Basis: Current FMP quote-based enterprise value / four-quarter operating income plus matched D&A. Source: stored company filings and market data; unavailable inputs remain N/A.
The EV/EBITDA ratio is N/A as of 2026-10-06T17:03:50.908Z.
Calculation as of: 2026-10-06T17:03:50.908Z.
Quote observation: 2026-10-06T17:00:56.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 2d10fe3d61b0e44c4972ff3bdbdc4638c39be0bdbd34ced4654fb4b6b9e88730
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2022-08-08.
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
EV/EBITDA RATIO
N/A
EV/EBITDA RATIO AVG TTM
15.28x
EV/EBITDA RATIO AVG 3Y
15.28x
EV/EBITDA RATIO AVG 5Y
15.28x
EV/EBITDA RATIO AVG 10Y
N/A
EV/EBITDA RATIO AVG 15Y
N/A
EV/EBITDA RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
Prothena Corporation plc
Market Cap
$413.59M
EV/EBITDA Ratio
N/A
TTM Avg
15.28x
3Y Avg
15.28x
5Y Avg
15.28x
Market Cap
$413.21M
EV/EBITDA Ratio
N/A
TTM Avg
30.26x
3Y Avg
22.88x
5Y Avg
18.64x
Market Cap
$410.92M
EV/EBITDA Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$410.57M
EV/EBITDA Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$419.40M
EV/EBITDA Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$406.54M
EV/EBITDA Ratio
N/A
TTM Avg
5.73x
3Y Avg
28.73x
5Y Avg
28.73x
| NAME | MARKET CAP | EV/EBITDA RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Prothena Corporation plc (PRTA) | $413.59M | N/A | 15.28x | 15.28x | 15.28x |
| Myriad Genetics, Inc. (MYGN)vs › | $413.21M | N/A | 30.26x | 22.88x | 18.64x |
| Rezolute, Inc. (RZLT)vs › | $415.14M | N/A | N/A | N/A | N/A |
| Eikon Therapeutics, Inc. Common Stock (EIKN)vs › | $410.92M | N/A | N/A | N/A | N/A |
| Strata Critical Medical, Inc. (SRTA)vs › | $410.57M | N/A | N/A | N/A | N/A |
| Shoulder Innovations, Inc. (SI)vs › | $409.89M | N/A | N/A | N/A | N/A |
| Neurogene Inc. (NGNE)vs › | $409.28M | N/A | N/A | N/A | N/A |
| Senseonics Holdings, Inc. (SENS)vs › | $419.40M | N/A | N/A | N/A | N/A |
| Atea Pharmaceuticals, Inc. (AVIR)vs › | $406.54M | N/A | 5.73x | 28.73x | 28.73x |
| ARS Pharmaceuticals, Inc. (SPRY)vs › | $423.53M | N/A | N/A | N/A | N/A |
EV/EBITDA = Enterprise Value / EBITDA (TTM)
Enterprise value to EBITDA is a capital-structure-neutral valuation multiple, useful for comparing companies with different debt levels and tax rates.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EV/EBITDA RATIO |
|---|---|
| 2022-08-08 | 15.04x |
| 2022-08-05 | 15.11x |
| 2022-08-04 | 14.52x |
| 2022-08-03 | 13.58x |
| 2022-08-02 | 12.76x |
| 2022-08-01 | 12.74x |
| 2022-07-29 | 13.68x |
| 2022-07-28 | 14.15x |
| 2022-07-27 | 14.23x |
| 2022-07-26 | 13.65x |
| 2022-07-25 | 13.56x |
| 2022-07-22 | 13.65x |
| 2022-07-21 | 14.93x |
| 2022-07-20 | 14.71x |
| 2022-07-19 | 13.88x |
| 2022-07-18 | 12.94x |
| 2022-07-15 | 13.44x |
| 2022-07-14 | 13.29x |
| 2022-07-13 | 13.29x |
| 2022-07-12 | 13.05x |
| 2022-07-11 | 12.92x |
| 2022-07-08 | 13.98x |
| 2022-07-07 | 13.45x |
| 2022-07-06 | 12.67x |
| 2022-07-05 | 12.73x |
| 2022-07-01 | 11.48x |
| 2022-06-30 | 10.96x |
| 2022-06-29 | 10.73x |
| 2022-06-28 | 10.70x |
| 2022-06-27 | 11.28x |
| 2022-06-24 | 11.39x |
| 2022-06-23 | 11.23x |
| 2022-06-22 | 10.12x |
| 2022-06-21 | 9.88x |
| 2022-06-17 | 8.68x |
| 2022-06-16 | 7.98x |
| 2022-06-15 | 8.55x |
| 2022-06-14 | 8.03x |
| 2022-06-13 | 7.89x |
| 2022-06-10 | 9.18x |
| 2022-06-09 | 10.80x |
| 2022-06-08 | 11.66x |
| 2022-06-07 | 11.86x |
| 2022-06-06 | 10.30x |
| 2022-06-03 | 11.21x |
| 2022-06-02 | 10.66x |
| 2022-06-01 | 10.52x |
| 2022-05-31 | 11.02x |
| 2022-05-27 | 11.69x |
| 2022-05-26 | 10.58x |
| 2022-05-25 | 9.99x |
| 2022-05-24 | 10.13x |
| 2022-05-23 | 10.46x |
| 2022-05-20 | 10.91x |
| 2022-05-19 | 10.30x |
| 2022-05-18 | 9.88x |
| 2022-05-17 | 11.52x |
| 2022-05-16 | 10.17x |
| 2022-05-13 | 10.37x |
| 2022-05-12 | 9.19x |
| 2022-05-11 | 9.40x |
| 2022-05-10 | 10.84x |
| 2022-05-09 | 10.89x |
| 2022-05-06 | 12.80x |
| 2022-05-05 | 10.76x |
| 2022-05-04 | 12.18x |
| 2022-05-03 | 11.23x |
| 2022-05-02 | 11.78x |
| 2022-04-29 | 10.84x |
| 2022-04-28 | 11.37x |
| 2022-04-27 | 9.55x |
| 2022-04-26 | 10.47x |
| 2022-04-25 | 13.45x |
| 2022-04-22 | 13.50x |
| 2022-04-21 | 14.48x |
| 2022-04-20 | 15.07x |
| 2022-04-19 | 14.53x |
| 2022-04-18 | 13.84x |
| 2022-04-14 | 15.30x |
| 2022-04-13 | 16.16x |
| 2022-04-12 | 14.84x |
| 2022-04-11 | 14.21x |
| 2022-04-08 | 15.56x |
| 2022-04-07 | 16.29x |
| 2022-04-06 | 16.87x |
| 2022-04-05 | 16.45x |
| 2022-04-04 | 17.75x |
| 2022-04-01 | 17.16x |
| 2022-03-31 | 15.57x |
| 2022-03-30 | 15.54x |
| 2022-03-29 | 16.60x |
| 2022-03-28 | 15.82x |
| 2022-03-25 | 15.81x |
| 2022-03-24 | 16.37x |
| 2022-03-23 | 15.40x |
| 2022-03-22 | 16.32x |
| 2022-03-21 | 16.27x |
| 2022-03-18 | 17.22x |
| 2022-03-17 | 15.99x |
| 2022-03-16 | 15.02x |
| 2022-03-15 | 13.50x |
| 2022-03-14 | 12.62x |
| 2022-03-11 | 13.57x |
| 2022-03-10 | 13.94x |
| 2022-03-09 | 13.94x |
| 2022-03-08 | 11.83x |
| 2022-03-07 | 11.55x |
| 2022-03-04 | 11.76x |
| 2022-03-03 | 12.90x |
| 2022-03-02 | 13.57x |
| 2022-03-01 | 13.56x |
| 2022-02-28 | 14.31x |
| 2022-02-25 | 16.08x |
| 2022-02-24 | 15.58x |
| 2022-02-23 | 14.15x |
| 2022-02-22 | 15.29x |
| 2022-02-18 | 14.97x |
| 2022-02-17 | 15.91x |
| 2022-02-16 | 17.39x |
| 2022-02-15 | 17.53x |
| 2022-02-14 | 16.17x |
| 2022-02-11 | 16.21x |
| 2022-02-10 | 16.53x |
| 2022-02-09 | 16.98x |
| 2022-02-08 | 15.73x |
| 2022-02-07 | 15.67x |
| 2022-02-04 | 15.00x |
| 2022-02-03 | 14.09x |
| 2022-02-02 | 14.34x |
| 2022-02-01 | 15.64x |
| 2022-01-31 | 15.25x |
| 2022-01-28 | 14.31x |
| 2022-01-27 | 13.48x |
| 2022-01-26 | 15.01x |
| 2022-01-25 | 15.40x |
| 2022-01-24 | 16.18x |
| 2022-01-21 | 16.02x |
| 2022-01-20 | 16.16x |
| 2022-01-19 | 16.63x |
| 2022-01-18 | 17.22x |
| 2022-01-14 | 18.92x |
| 2022-01-13 | 17.38x |
| 2022-01-12 | 17.53x |
| 2022-01-11 | 20.66x |
| 2022-01-10 | 20.49x |
| 2022-01-07 | 20.04x |
| 2022-01-06 | 21.69x |
| 2022-01-05 | 22.42x |
| 2022-01-04 | 23.83x |
| 2022-01-03 | 25.45x |
| 2021-12-31 | 25.57x |
| 2021-12-30 | 24.44x |
| 2021-12-29 | 23.84x |
| 2021-12-28 | 23.08x |
| 2021-12-27 | 24.24x |
| 2021-12-23 | 24.89x |
| 2021-12-22 | 24.01x |
| 2021-12-21 | 23.97x |
| 2021-12-20 | 23.55x |
| 2021-12-17 | 23.95x |
| 2021-12-16 | 21.49x |
| 2021-12-15 | 22.71x |
| 2021-12-14 | 20.66x |
| 2021-12-13 | 22.05x |
| 2021-12-10 | 21.73x |
| 2021-12-09 | 22.60x |
| 2021-12-08 | 25.67x |
| 2021-12-07 | 25.54x |
| 2021-12-06 | 21.97x |
| 2021-12-03 | 23.68x |
| 2021-12-02 | 25.75x |
| 2021-12-01 | 23.72x |
| 2021-11-30 | 26.07x |
| 2021-11-29 | 25.45x |
| 2021-11-26 | 25.40x |
| 2021-11-24 | 28.43x |
| 2021-11-23 | 26.76x |
| 2021-11-22 | 32.04x |
| 2021-11-19 | 31.86x |
| 2021-11-18 | 29.07x |
| 2021-11-17 | 30.35x |
| 2021-11-16 | 29.85x |
| 2021-11-15 | 30.82x |
| 2021-11-12 | 30.82x |
| 2021-11-11 | 30.36x |
| 2021-11-10 | 30.08x |
| 2021-11-09 | 30.37x |
| 2021-11-08 | 31.71x |
| 2021-11-05 | 32.00x |
| 2014-11-03 | 3853.88x |
| 2014-10-31 | 3741.55x |
| 2014-10-30 | 3499.61x |
| 2014-10-29 | 3318.15x |
| 2014-10-28 | 3460.73x |
| 2014-10-27 | 2812.67x |
| 2014-10-24 | 3296.55x |
| 2014-10-23 | 3153.98x |
| 2014-10-22 | 2471.36x |
| 2014-10-21 | 2825.63x |
| 2014-10-20 | 2968.20x |
| 2014-10-17 | 2890.44x |
| 2014-10-16 | 2847.23x |
| 2014-10-15 | 2449.76x |
| 2014-10-14 | 1957.23x |
| 2014-10-13 | 1818.98x |
| 2014-10-10 | 2207.82x |
| 2014-10-09 | 2998.44x |
| 2014-10-08 | 3300.87x |
| 2014-10-07 | 2873.15x |
| 2014-10-06 | 3080.53x |
| 2014-10-03 | 3512.57x |
| 2014-10-02 | 3646.50x |
| 2014-10-01 | 3370.00x |
| 2014-09-30 | 3840.92x |
| 2014-09-29 | 4108.78x |
| 2014-09-26 | 4018.05x |
| 2014-09-25 | 3884.12x |
| 2014-09-24 | 4311.84x |
| 2014-09-23 | 4078.54x |
| 2014-09-22 | 3961.89x |
| 2014-09-19 | 4424.17x |
| 2014-09-18 | 4160.63x |
| 2014-09-17 | 4476.01x |
| 2014-09-16 | 3944.61x |
| 2014-09-15 | 3763.15x |
| 2014-09-12 | 4368.00x |
| 2014-09-11 | 4635.87x |
| 2014-09-10 | 4527.86x |
| 2014-09-09 | 4160.63x |
| 2014-09-08 | 4424.17x |
| 2014-09-05 | 4320.48x |
| 2014-09-04 | 4359.36x |
| 2014-09-03 | 4311.84x |
| 2014-09-02 | 4251.35x |
| 2014-08-29 | 4160.63x |
| 2014-08-28 | 3996.45x |
| 2014-08-27 | 4039.66x |
| 2014-08-26 | 4203.83x |
| 2014-08-25 | 3745.87x |
| 2014-08-22 | 3551.45x |
| 2014-08-21 | 3447.76x |
| 2014-08-20 | 3382.96x |
| 2014-08-19 | 3374.32x |
| 2014-08-18 | 3395.92x |
| 2014-08-15 | 3300.87x |
| 2014-08-14 | 3452.08x |
| 2014-08-13 | 3201.50x |
| 2014-08-12 | 3361.36x |
| 2014-08-11 | 3223.10x |
| 2014-08-08 | 3128.06x |
| 2014-08-07 | 2700.34x |
| 2014-08-06 | 2484.32x |
| 2014-08-05 | 2678.74x |
